Resources

Resources & News

No Results Found

Try adjusting your search to find what you’re looking for.

BioPharma: CDMO requires quality, speed, and service

Case Studies
Feb 12, 2023
Southeast US-based biologic drug contract development and manufacturing organization (CDMO) supporting early-stage product development to cGMP commercial manufacturing had experienced significant challenges finding CMO partners willing and able to address their needs, which included small to large cGMP batch sizes, short lead times, as well as services related to stability studies for new solutions.

Research: Core lab improves customer service

Case Studies
Feb 12, 2023
Northeast US-based core laboratory supporting multiple research labs was expending limited resources on down packaging FBS into smaller sized packaging (100mL) to simplify the process of aliquoting FBS by the labs and researchers supported by the core lab.

Cell Therapy: Scaling to cGMP buffers 

Case Studies
Feb 12, 2023
US-based Cell Therapy company that is part of a global > $50B market cap biopharmaceutical company needed an external manufacturer who could make cGMP process liquids – cost effectively – in the small aliquots required for their current workflow process steps.

Life Science Tools:  Outsource lab scale liquids

Case Studies
Feb 13, 2023
APAC-based, > $15B market cap, global cell culture tools company focused on leveraging self-manufacturing footprint for higher-value proprietary media products and custom manufacturing for end customers.

Gene Therapy:  Internal manufacturing cannot scale

Case Studies
Feb 13, 2023
Southeast US-based Gene Therapy company scaling to clinical stage had been making required process liquids – lab scale – internally, but required an outsourcing partner to simplify the workflow with pre-made process liquids much larger than the internal lab could manage – and can scale to cGMP when needed.

GeminiBio Announces Addition of Gopi Natarajan to Board of Directors

News
Mar 16, 2023
Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Gopi Natarajan to the Board of Directors.

GeminiBio Strengthens Board Directors with Addition of Bryan Poltilove

News
Mar 24, 2023
Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, and BroadOak Capital Partners, a life science focused investment firm, announced today the appointment of Bryan Poltilove to the Board of Directors.